Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 24, 2022
- Accession no.
- 0001225208-22-003275
- Filed
- Feb 24, 2022
- Trade date
- Feb 22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.27M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Common Stock | MOption exerciseAcquired | +16,863 | $17.26 | +$291,055.38 | 289,689 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseAcquired | +15,086 | $16.31 | +$246,052.66 | 304,775 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseAcquired | +13,661 | $13.08 | +$178,685.88 | 318,436 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseAcquired | +7,572 | $7.39 | +$55,957.08 | 326,008 | Direct | |
| Feb 22, 2022 | Common Stock | SSaleDisposed | −53,182 | $42.75F2 | −$2,273,530.5 | 272,826 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 | Common Stock | AGrant or awardAcquired | +23,979 | $0.00 | $0 | 23,979 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseDisposed | −16,863 | $0.00 | $0 | 50,591 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseDisposed | −15,086 | $0.00 | $0 | 45,259 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseDisposed | −13,661 | $0.00 | $0 | 27,323 | Direct | |
| Feb 22, 2022 | Common Stock | MOption exerciseDisposed | −7,572 | $0.00 | $0 | 7,572 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $42.48 to $43.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.